Neurogene Inc. (NGNE) Institutional Ownership

Ownership Summary

A total of 86 institutions have reported a stake in Neurogene Inc. (NASDAQ:NGNE) as of September 2025, according to recent 13F filings with the SEC.

• Institutional ownership in Neurogene edged down to 107.1% in September 2025, compared to 108.0% in June 2025.
• Institutional share ownership changed by 2.65% QoQ, while the number of institutional owners saw no change YoY.
• A review of institutional activity for Neurogene shows 35 of 86 filers increasing their positions, while 30 reduced their stake, and 21 remained unchanged.
• This class of investors increased its holdings in Neurogene to 15.29Mn shares for the 13F-cycle ending September 2025, up by 394.38K shares quarter on quarter, and up 1.44Mn shares year over year.
• Samsara BioCapital, LLC continues to be the largest institutional holder of Neurogene as of September 30, 2025, with a position of 1.72Mn shares, representing 12.03% of the company's outstanding stock.
• Among the most significant buyers of Neurogene during September 2025 were BALYASNY ASSET MANAGEMENT L.P. (699.00K), JENNISON ASSOCIATES LLC (226.53K), GOLDMAN SACHS GROUP INC (55.51K), JANE STREET GROUP, LLC (52.11K), Trexquant Investment LP (39.48K).
• Leading sellers of Neurogene stock in September 2025 included FMR LLC (352.93K), MORGAN STANLEY (119.03K), MILLENNIUM MANAGEMENT LLC (59.94K), BANK OF AMERICA CORP /DE/ (54.85K), Octagon Capital Advisors LP (51.00K).
• The top 10 institutional holders of Neurogene for the quarter ending September 2025 included Samsara BioCapital, LLC (1.72Mn), RTW INVESTMENTS, LP (1.36Mn), Redmile Group, LLC (1.30Mn), Casdin Capital, LLC (1.30Mn), EcoR1 Capital, LLC (1.27Mn), BAKER BROS. ADVISORS LP (991.69K), BlackRock, Inc. (951.10K), BALYASNY ASSET MANAGEMENT L.P. (699.00K), TORONTO DOMINION BANK (681.34K), VANGUARD GROUP INC (604.61K).